{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:07:04Z","timestamp":1770840424982,"version":"3.50.1"},"reference-count":26,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/terarkh201587764-71","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T15:31:56Z","timestamp":1460647916000},"page":"64","source":"Crossref","is-referenced-by-count":22,"title":["Clinical and morphological features of different types of Castleman\u2019s disease"],"prefix":"10.26442","volume":"87","author":[{"given":"A. L.","family":"Melikyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. K.","family":"Egorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0410. \u041c.","family":"Kovrigina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. N.","family":"Subortseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Gilyazitdinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Karagyulyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Silaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. G.","family":"Gemdzhian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. G.","family":"Savchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201587764-71-1","doi-asserted-by":"crossref","unstructured":"Castleman B, Thowne VW. Case records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011. New Engl J Med. 1954;250:26-30.","DOI":"10.1056\/NEJM195401072500107"},{"key":"key-10.17116\/terarkh201587764-71-2","doi-asserted-by":"crossref","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):822-830.","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"key-10.17116\/terarkh201587764-71-3","doi-asserted-by":"crossref","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670-683.","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"key-10.17116\/terarkh201587764-71-4","unstructured":"Flendring JA. Benign giant lymphoma: Clinicopathologic correlation study, in Clark RL, Cumley RS. The Year book of cancer. Chicago: Year book; 1986:296."},{"key":"key-10.17116\/terarkh201587764-71-5","doi-asserted-by":"crossref","unstructured":"Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69(1):86-90.","DOI":"10.1093\/ajcp\/69.1.86"},{"key":"key-10.17116\/terarkh201587764-71-6","doi-asserted-by":"crossref","unstructured":"Martin JM, Bell B, Ruether BA. Giant lymph node hyperplasia (Castleman\u2019s disease) of hyaline vascular type. Clinical heterogeneity with immunohistologic uniformity. Am J Clin Pathol. 1985;84(4):439-446.","DOI":"10.1093\/ajcp\/84.4.439"},{"key":"key-10.17116\/terarkh201587764-71-7","doi-asserted-by":"crossref","unstructured":"Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: clinical findings and clinicopathologic correlation in 15 patients. J Clin Oncol. 1985;3(3):1202.","DOI":"10.1200\/JCO.1985.3.9.1202"},{"key":"key-10.17116\/terarkh201587764-71-8","unstructured":"Frizzera G. Castleman\u2019s disease and related disorders. Semin DiagnPathol. 1988;5(4):346-364."},{"key":"key-10.17116\/terarkh201587764-71-9","unstructured":"Hanson CA, Frizzera G, Patton DF, Peretson BA, McClain KL, Gajl-Peczalska KJ, Kersey JH. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman\u2019s disease: association with Epstein Barr virus. Am J Pathol. 1988;131(1):84-91."},{"key":"key-10.17116\/terarkh201587764-71-10","doi-asserted-by":"crossref","unstructured":"Soulier J, Grollet L, Oksenhendler E, Miciea J-M, Cacoub P, Baruchel A, Brice P, Clauvel J-P, d\u2019Agay M-F, Raphael M, Sigaux F. Molecular analysis of clonality in Castleman\u2019s disease. Blood. 1995;86(3):1131-1138.","DOI":"10.1182\/blood.V86.3.1131.1131"},{"key":"key-10.17116\/terarkh201587764-71-11","doi-asserted-by":"crossref","unstructured":"Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Lee T, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic signi\ufb01cance of interleukin-6 (IL-6\/BSF-2) in Castleman\u2019s disease. Blood. 1989;74(4):1360-1367.","DOI":"10.1182\/blood.V74.4.1360.1360"},{"key":"key-10.17116\/terarkh201587764-71-12","doi-asserted-by":"crossref","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma. Science. 1994;266(5192): 865-1869.","DOI":"10.1126\/science.7997879"},{"key":"key-10.17116\/terarkh201587764-71-13","doi-asserted-by":"crossref","unstructured":"Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D. Lytic growth of Kaposi\u2019s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2(3):342-346.","DOI":"10.1038\/nm0396-342"},{"key":"key-10.17116\/terarkh201587764-71-14","doi-asserted-by":"crossref","unstructured":"El-Osta HE, Kurzrock R. Castleman\u2019s disease: from basic mechanisms to molecular therapeutics. Oncologist. 2011;16(4):497-511.","DOI":"10.1634\/theoncologist.2010-0212"},{"key":"key-10.17116\/terarkh201587764-71-15","doi-asserted-by":"crossref","unstructured":"Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br JHaematol. 2005;129(1):3-17. Review.","DOI":"10.1111\/j.1365-2141.2004.05311.x"},{"key":"key-10.17116\/terarkh201587764-71-16","doi-asserted-by":"crossref","unstructured":"Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF. The management of unicentric and multicentric Castleman\u2019s disease: a report of 16 cases and a review of the literature. Cancer. 1999;85(3):706-717.","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7"},{"key":"key-10.17116\/terarkh201587764-71-17","doi-asserted-by":"crossref","unstructured":"McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program. 2004:283-296.","DOI":"10.1182\/asheducation-2004.1.283"},{"key":"key-10.17116\/terarkh201587764-71-18","doi-asserted-by":"crossref","unstructured":"Kim JE, Kim JC, Park IA, Kim WH, Seo JW, Jang JJ, Kim CW, Park SH, Lee HS, Chi JG, Kim YI, Ham EK. Clinicopathologic study of Castleman\u2019s disease in Korea. J Korean Med Sci. 2000;15(4):393-398.","DOI":"10.3346\/jkms.2000.15.4.393"},{"key":"key-10.17116\/terarkh201587764-71-19","doi-asserted-by":"crossref","unstructured":"Saeed-Abdul-Rahman I, Al-Amri AM. Castleman disease. Korean JHematol. 2012;47(3):163-177.","DOI":"10.5045\/kjh.2012.47.3.163"},{"key":"key-10.17116\/terarkh201587764-71-20","doi-asserted-by":"crossref","unstructured":"Cronin DM, Warnke RA. Castleman disease: an update on classi\ufb01cation and the spectrum of associated lesions. Adv AnatPathol. 2009;16(4):236-246.","DOI":"10.1097\/PAP.0b013e3181a9d4d3"},{"key":"key-10.17116\/terarkh201587764-71-21","doi-asserted-by":"crossref","unstructured":"Talat N, Schulte KM. Castleman\u2019s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16(9):1316-1324.","DOI":"10.1634\/theoncologist.2011-0075"},{"key":"key-10.17116\/terarkh201587764-71-22","doi-asserted-by":"crossref","unstructured":"Menke DM. Ly-1b cells and Castleman disease. Blood. 2000;96(4):1614-1616.","DOI":"10.1182\/blood.V96.4.1614"},{"key":"key-10.17116\/terarkh201587764-71-23","doi-asserted-by":"crossref","unstructured":"Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406-1412.","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412"},{"key":"key-10.17116\/terarkh201587764-71-24","unstructured":"Ioachim HL, Howard R. Ioachims lymph node pathology. Textbook and color atlas. Philadelphia: JB Lippinott Co; 2006: Chapter 43:246-253."},{"key":"key-10.17116\/terarkh201587764-71-25","unstructured":"Melikyan A.L., Kaplanskaya I.B., Korneva E.P., Frank G.A. Bolezn' Kastlemana. Terapevticheskii arkhiv 2005;7:48-53."},{"key":"key-10.17116\/terarkh201587764-71-26","unstructured":"Melikyan A.L. Bolezn' Kastlemana. Atlas. Opukholi limfaticheskoi sistemy. Pod red. Vorob'eva A.I., Kremenetskoi A.M. M.; 2007:259-262."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:52:29Z","timestamp":1600451549000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2015\/7\/downloads\/ru\/380040-36602015078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"alternative-id":["terarkh201587764-71"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201587764-71","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}